Abstract:5539 Previous studies have suggested that the sphingosine kinase 1 (SPHK1) gene can act as an oncogene, mediating various cellular functions such as cell proliferation, apoptosis inhibition and cell transformation and migration. The current study was conducted to investigate the expression of SPHK1 in human astrocytomas and to characterize its association with the clinical progression of astrocytomas. Our results of Western blotting and RT-PCR showed that SPHK1 mRNA and protein were upregulated in astrocytoma cell lines, as well as in astrocytoma tissues when compared with paired adjacent non-cancerous tissues from the same patients. In addition, 243 paraffin-embedded archival astrocytoma tissues were examined with immunohistochemical staining, among which 227 paraffin-embedded archival astrocytomas biopsies displayed moderate to strong cytoplasmic staining of SPHK1 in astrocytomas cells, whereas no significant staining of SPHK1 was detected in the adjacent non-cancerous epithelial cells. These data supported the notion that SPHK1 might play a role in the development and progression of astrocytomas. Quantitative SPHK1 immunohistochemical staining demonstrated that the SPHK1 expression level increased in parallel with the development and progression of astrocytomas. Further analysis of the relationship between SPHK1 staining and the clinical characteristics of patients showed a significant correlation of SPHK1 expression with the clinocopathological staging, while it was not correlated to the age and gender in astrocytomas patients, strongly suggesting that SPHK1 might be useful as an independent marker to identify subsets of astrocytomas patients with more aggressive disease. Furthermore, patients with high SPHK1 expression revealed a cumulative 3-year survival rate of 10.3% (n=100, 95% confidence interval, 0.041-0.165), as compared with the 57.7% (95% confidence interval, 0.517-0.637) cumulative 3-year survival rate in the low SPHK1 group (n =143), suggesting the possibility to use SPHK1 as a predictor for patient prognosis and survival. It is also noteworthy that the predictive significance of SPHK1 expression for poorer prognosis was identified in both relatively early- (grade I and II) and late-stage (grade III and IV) patient subgroups. Taken together, our data strongly suggest the usefulness of SPHK1 expression as a prognostic marker for astrocytoma patients.

The Clinical Significance of Sphk1 Expression in Human Astrocytomas Progression and Overall Patient Survival

Clinical Significance of Sphingosine Kinase-1 Expression in Human Astrocytomas Progression and Overall Patient Survival

Increased Sphingosine Kinase 1 Expression is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis

Identification of Spindle and Kinetochore-Associated Family Genes As Therapeutic Targets and Prognostic Biomarkers in Pancreas Ductal Adenocarcinoma Microenvironment

Sphingosine Kinase 1 is Associated with Gastric Cancer Progression and Poor Survival of Patients

[Relationship Between Sphingosine Kinase 1 Expression and Tumor Invasion, Metastasis and Prognosis in Gastric Cancer].

Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy

Prognostic Significance Of Integrin-Linked Kinase1 Overexpression In Astrocytoma

The Expression of P57kip2 and P27kip1 in Human Brain Astrocytoma and the Prognostic Significance

Elevated Expression Of Hsp10 Protein Inhibits Apoptosis And Associates With Poor Prognosis Of Astrocytoma

Increased SPHK1 expression is associated with poor prognosis in bladder cancer

Nucleolar and Spindle Associated Protein 1 Promotes the Aggressiveness of Astrocytoma by Activating the Hedgehog Signaling Pathway

High expression of SPHK1 in sacral chordoma and association with patients’ poor prognosis

Prognostic Biomarker GSTK1 in Head and Neck Squamous Cell Carcinoma and Its Correlation with Immune Infiltration and DNA Methylation

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF- κ B /IL-6/STAT3 and JNK/PTX3 pathways

Clinical significance of immunohistochemically detecting forkhead box P3 expression in human astrocytic tumors

SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma

Prognostic Roles of the Expression of Sphingosine-1-phosphate Metabolism Enzymes in Non-Small Cell Lung Cancer

The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.

Elevated Levels of P-Mnk1, P-Eif4e and P-P70s6k Proteins Are Associated with Tumor Recurrence and Poor Prognosis in Astrocytomas.

Nerve Growth Factor Expression in Astrocytoma and Cerebrospinal Fluid: a New Biomarker for Prognosis of Astrocytoma.